-
Panel discussion addresses potential and challenges of stem cell-derived beta cell therapy for type 1 diabetes
Trevor Reichman, MD, moderated the discussion, which included insights into eligibility criteria, immunosuppression, regulatory concerns, and top priorities.
-
Experts to share updates on immunotherapy trials in type 1 diabetes
Researchers, including Cate Speake, PhD, and Lauren Higdon, PhD, will share new insights into early intervention aimed at altering the progression of this type of diabetes by targeting different aspects of the immune system.
-
Presenter Profile: Modeling Diabetic Alpha-Cell Dysfunction Using Stem Cell-Derived Islets
Quinn Peterson, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 4:30 p.m. CT.
-
Presenter Profile: Type 1 Diabetes Neoantigens Hidden in the Dark Proteome
Neelanjan Mukherjee, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 4:30 p.m. CT.
-
Presenter Profile: Placental Mimicry Approach to Induce Tolerance toward Insulin Secreting Cell Therapies
Jessica Weaver, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 1:30 p.m. CT.
-
Presenter Profile: Islet-Like Cells Generated from HLA-Edited Pluripotent Stem Cells Avoid Allorejection from T Cells, NKG2A+ NK Cells, and Allograft- Specific Antibodies
Paraish Misra, MD, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 1:30 p.m. CT.
-
Presenter Profile: Age-Related Adipose Remodeling and Metabolic Dysfunction
Qiong Annabel Wang, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person 12:00 a.m., at 8:00 a.m. CT.
-
Presenter Profile: Engineering Genome-Scale, High-Throughput Platforms for De Novo T Cell Epitope Discovery
Mohammad Haj Dezfulian, PhD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Saturday, June 6, at 8:00 a.m. CT.
-
Panel discussion to explore stem cell-derived beta cell therapy for type 1 diabetes
Sanjoy Dutta, PhD, Jay Skyler, MD, and other panelists will share insights on advances in the use of manufactured islets and what it might take to achieve widespread clinical use.
-
New clinical trial results to debut daily in New Orleans
Investigators will present high-impact results for type 1 diabetes, type 2 diabetes, and obesity in several clinical trial sessions. Glucagon-like peptide-1 (GLP-1)-based therapies—including dual and triple agonists, oral agents, and longer acting formulations—will be a recurring topic.